The MHC-I antigen presentation pathway processes mutant tumor proteins, which are loaded onto MHC-I molecules and presented to CD8 T cells, thereby enabling specific cytotoxic responses that eliminate tumor cells with the neoantigens on their cell surfaces. The gene discussed is CD8A; the disease is neoplasm.